3D Bioprinting Human‐Induced Pluripotent Stem Cells and Drug‐Releasing Microspheres to Produce Responsive Neural Tissues

3D bioprinting can produce complex human tissue mimics using stem cells (SCs). Herein, cylindrical constructs containing human‐induced pluripotent stem cell (hiPSC)‐derived neural progenitor cells (NPCs) encapsulated in a fibrin‐based bioink containing polycaprolactone (PCL)–retinoic acid (RA) and p...

Full description

Bibliographic Details
Main Authors: Laura De la Vega, Laila Abelseth, Ruchi Sharma, Juan Triviño-Paredes, Milena Restan, Stephanie M. Willerth
Format: Article
Language:English
Published: Wiley-VCH 2021-08-01
Series:Advanced NanoBiomed Research
Subjects:
Online Access:https://doi.org/10.1002/anbr.202000077
_version_ 1819021964528844800
author Laura De la Vega
Laila Abelseth
Ruchi Sharma
Juan Triviño-Paredes
Milena Restan
Stephanie M. Willerth
author_facet Laura De la Vega
Laila Abelseth
Ruchi Sharma
Juan Triviño-Paredes
Milena Restan
Stephanie M. Willerth
author_sort Laura De la Vega
collection DOAJ
description 3D bioprinting can produce complex human tissue mimics using stem cells (SCs). Herein, cylindrical constructs containing human‐induced pluripotent stem cell (hiPSC)‐derived neural progenitor cells (NPCs) encapsulated in a fibrin‐based bioink containing polycaprolactone (PCL)–retinoic acid (RA) and purmorphamine (puro)‐releasing microspheres are bioprinted in a layer‐by‐layer fashion using the microfluidic‐based RX1 bioprinter to engineer responsive neural tissues. The differentiated constructs contain neurons expressing ChAT, GABA, and MAP2, astrocytes expressing GFAP, and oligodendrocytes expressing O4 as indicated by immunocytochemistry and flow cytometry analysis on days 30 and 45. The bioprinted tissues also respond to treatment with acetylcholine (Ach) and gamma‐aminobutyric acid (GABA) on days 30 and 45. The use of microsphere‐laden bioinks efficiently promotes neural tissue differentiation and maturation in situ using a lower amount of morphogens in comparison with using soluble drugs. This bioprinting strategy serves as a cost‐effective solution for engineering humanized neural tissues.
first_indexed 2024-12-21T04:15:28Z
format Article
id doaj.art-81ffe12472044cce8fbdcbc1b4abf313
institution Directory Open Access Journal
issn 2699-9307
language English
last_indexed 2024-12-21T04:15:28Z
publishDate 2021-08-01
publisher Wiley-VCH
record_format Article
series Advanced NanoBiomed Research
spelling doaj.art-81ffe12472044cce8fbdcbc1b4abf3132022-12-21T19:16:20ZengWiley-VCHAdvanced NanoBiomed Research2699-93072021-08-0118n/an/a10.1002/anbr.2020000773D Bioprinting Human‐Induced Pluripotent Stem Cells and Drug‐Releasing Microspheres to Produce Responsive Neural TissuesLaura De la Vega0Laila Abelseth1Ruchi Sharma2Juan Triviño-Paredes3Milena Restan4Stephanie M. Willerth5Department of Mechanical Engineering University of Victoria Victoria V8W 2Y2 CanadaBiomedical Engineering Program University of Victoria Victoria V8W 2Y2 CanadaDepartment of Mechanical Engineering University of Victoria Victoria V8W 2Y2 CanadaDivision of Medical Sciences University of Victoria Victoria V8W 2Y2 CanadaBiomedical Engineering Program University of Victoria Victoria V8W 2Y2 CanadaDepartment of Mechanical Engineering University of Victoria Victoria V8W 2Y2 Canada3D bioprinting can produce complex human tissue mimics using stem cells (SCs). Herein, cylindrical constructs containing human‐induced pluripotent stem cell (hiPSC)‐derived neural progenitor cells (NPCs) encapsulated in a fibrin‐based bioink containing polycaprolactone (PCL)–retinoic acid (RA) and purmorphamine (puro)‐releasing microspheres are bioprinted in a layer‐by‐layer fashion using the microfluidic‐based RX1 bioprinter to engineer responsive neural tissues. The differentiated constructs contain neurons expressing ChAT, GABA, and MAP2, astrocytes expressing GFAP, and oligodendrocytes expressing O4 as indicated by immunocytochemistry and flow cytometry analysis on days 30 and 45. The bioprinted tissues also respond to treatment with acetylcholine (Ach) and gamma‐aminobutyric acid (GABA) on days 30 and 45. The use of microsphere‐laden bioinks efficiently promotes neural tissue differentiation and maturation in situ using a lower amount of morphogens in comparison with using soluble drugs. This bioprinting strategy serves as a cost‐effective solution for engineering humanized neural tissues.https://doi.org/10.1002/anbr.202000077bioprintingdrug releasingfibrinmicrospheresneural tissuesstem cells
spellingShingle Laura De la Vega
Laila Abelseth
Ruchi Sharma
Juan Triviño-Paredes
Milena Restan
Stephanie M. Willerth
3D Bioprinting Human‐Induced Pluripotent Stem Cells and Drug‐Releasing Microspheres to Produce Responsive Neural Tissues
Advanced NanoBiomed Research
bioprinting
drug releasing
fibrin
microspheres
neural tissues
stem cells
title 3D Bioprinting Human‐Induced Pluripotent Stem Cells and Drug‐Releasing Microspheres to Produce Responsive Neural Tissues
title_full 3D Bioprinting Human‐Induced Pluripotent Stem Cells and Drug‐Releasing Microspheres to Produce Responsive Neural Tissues
title_fullStr 3D Bioprinting Human‐Induced Pluripotent Stem Cells and Drug‐Releasing Microspheres to Produce Responsive Neural Tissues
title_full_unstemmed 3D Bioprinting Human‐Induced Pluripotent Stem Cells and Drug‐Releasing Microspheres to Produce Responsive Neural Tissues
title_short 3D Bioprinting Human‐Induced Pluripotent Stem Cells and Drug‐Releasing Microspheres to Produce Responsive Neural Tissues
title_sort 3d bioprinting human induced pluripotent stem cells and drug releasing microspheres to produce responsive neural tissues
topic bioprinting
drug releasing
fibrin
microspheres
neural tissues
stem cells
url https://doi.org/10.1002/anbr.202000077
work_keys_str_mv AT lauradelavega 3dbioprintinghumaninducedpluripotentstemcellsanddrugreleasingmicrospherestoproduceresponsiveneuraltissues
AT lailaabelseth 3dbioprintinghumaninducedpluripotentstemcellsanddrugreleasingmicrospherestoproduceresponsiveneuraltissues
AT ruchisharma 3dbioprintinghumaninducedpluripotentstemcellsanddrugreleasingmicrospherestoproduceresponsiveneuraltissues
AT juantrivinoparedes 3dbioprintinghumaninducedpluripotentstemcellsanddrugreleasingmicrospherestoproduceresponsiveneuraltissues
AT milenarestan 3dbioprintinghumaninducedpluripotentstemcellsanddrugreleasingmicrospherestoproduceresponsiveneuraltissues
AT stephaniemwillerth 3dbioprintinghumaninducedpluripotentstemcellsanddrugreleasingmicrospherestoproduceresponsiveneuraltissues